Krish S Krishnan
CEO, President at Krystal Biotech, Inc. (KRYS)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $34.3M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 4SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 5201,372,023 held (−0%) | $354.54 | $184K | -6.5% |
| Sep 4SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 2,0291,369,994 held (−0%) | $355.57 | $721K | -6.7% |
| Sep 4SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 3,2971,366,697 held (−0%) | $356.37 | $1.2M | -6.9% |
| Sep 4SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 3,9811,362,716 held (−0%) | $357.57 | $1.4M | -7.3% |
| Sep 4SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 3,1431,359,573 held (−0%) | $358.42 | $1.1M | -7.5% |
| Sep 4SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 3,3571,356,216 held (−0%) | $359.39 | $1.2M | -7.7% |
| Sep 4SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 2,2661,353,950 held (−0%) | $360.46 | $817K | -8.0% |
| Sep 4SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 1,2141,352,736 held (−0%) | $361.61 | $439K | -8.3% |
| Sep 4SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 2,0101,350,726 held (−0%) | $362.65 | $729K | -8.6% |
| Sep 4SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 5731,350,153 held (−0%) | $363.34 | $208K | -8.7% |
| Sep 4SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 1,3581,348,795 held (−0%) | $364.48 | $495K | -9.0% |
| Sep 4SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 8471,347,948 held (−0%) | $365.42 | $310K | -9.3% |
| Sep 4SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 4051,347,543 held (−0%) | $366.56 | $148K | -9.5% |
| Jun 5SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 3201,474,933 held (−0%) | $300.75 | $96K | +10.3% |
| Jun 5SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 6401,474,293 held (−0%) | $302.24 | $193K | +9.7% |
| Jun 5SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 1761,474,117 held (−0%) | $303.17 | $53K | +9.4% |
| Jun 5SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 5441,473,573 held (−0%) | $304.81 | $166K | +8.8% |
| Jun 5SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 5891,472,984 held (−0%) | $306.33 | $180K | +8.3% |
| Jun 5SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 11,4611,461,523 held (−1%) | $307.68 | $3.5M | +7.8% |
| Jun 5SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 4,8301,456,693 held (−0%) | $308.47 | $1.5M | +7.5% |
| Jun 5SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 2,7841,453,909 held (−0%) | $309.49 | $862K | +7.1% |
| Jun 5SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 2,6521,451,257 held (−0%) | $310.43 | $823K | +6.8% |
| Jun 5SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 9641,450,293 held (−0%) | $311.36 | $300K | +6.5% |
| Jun 5SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 401,450,253 held (−0%) | $312.23 | $12K | +6.2% |
| Mar 6SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 4831,499,770 held (−0%) | $257.31 | $124K | +28.9% |
| Mar 6SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 4701,499,300 held (−0%) | $258.38 | $121K | +28.3% |
| Mar 6SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 1,3771,497,923 held (−0%) | $259.87 | $358K | +27.6% |
| Mar 6SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 3,1281,494,795 held (−0%) | $260.49 | $815K | +27.3% |
| Mar 6SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 2,9621,491,833 held (−0%) | $261.41 | $774K | +26.9% |
| Mar 6SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 2,3801,489,453 held (−0%) | $262.44 | $625K | +26.4% |
| Mar 6SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 2,0431,487,410 held (−0%) | $263.70 | $539K | +25.8% |
| Mar 6SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 8,7981,478,612 held (−1%) | $264.85 | $2.3M | +25.2% |
| Mar 6SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 2,4391,476,173 held (−0%) | $265.59 | $648K | +24.9% |
| Mar 6SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 9201,475,253 held (−0%) | $266.56 | $245K | +24.4% |
| Dec 5SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 9561,507,100 held (−0%) | $214.28 | $205K | +54.8% |
| Dec 5SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 3441,506,756 held (−0%) | $215.48 | $74K | +53.9% |
| Dec 5SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 1,6001,505,156 held (−0%) | $217.04 | $347K | +52.8% |
| Dec 5SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 2,5771,502,579 held (−0%) | $218.72 | $564K | +51.6% |
| Dec 5SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 5,6931,496,886 held (−0%) | $219.55 | $1.2M | +51.0% |
| Dec 5SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 2,6251,494,261 held (−0%) | $220.34 | $578K | +50.5% |
| Dec 5SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 10,5051,483,756 held (−1%) | $221.78 | $2.3M | +49.5% |
| Dec 5SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 7001,483,056 held (−0%) | $222.20 | $156K | +49.2% |
| Dec 5SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 7001,438,011 held (−0%) | $214.25 | $150K | +54.8% |
| Dec 5SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 6001,437,411 held (−0%) | $215.49 | $129K | +53.9% |
| Dec 5SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 1,4001,436,011 held (−0%) | $216.97 | $304K | +52.8% |
| Dec 5SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 3,5931,432,418 held (−0%) | $218.83 | $786K | +51.5% |
| Dec 5SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 5,4191,426,999 held (−0%) | $219.68 | $1.2M | +51.0% |
| Dec 5SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 2,6271,424,372 held (−0%) | $220.52 | $579K | +50.4% |
| Dec 5SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 10,4611,413,911 held (−1%) | $221.82 | $2.3M | +49.5% |
| Dec 5SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 2001,413,711 held (−0%) | $222.38 | $44K | +49.1% |
- Sell
CEO, President Krish S Krishnan sold $184K of KRYS at $354.54 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President Krish S Krishnan sold $721K of KRYS at $355.57 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President Krish S Krishnan sold $1.2M of KRYS at $356.37 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President Krish S Krishnan sold $1.4M of KRYS at $357.57 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President Krish S Krishnan sold $1.1M of KRYS at $358.42 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President Krish S Krishnan sold $1.2M of KRYS at $359.39 — pre-scheduled 10b5-1 plan sale.